Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

[Comments of the DGP on the press release dated 21.10. 2011 of the National Heart, Lung and Blood Institute about the PANTHER Study on IPF patients].

Behr J, Costabel U, Worth H.

Pneumologie. 2011 Dec;65(12):724-5. doi: 10.1055/s-0031-1291535. Epub 2011 Dec 5. German. No abstract available.

2.

Hot off the breath: triple therapy for idiopathic pulmonary fibrosis--hear the PANTHER roar.

McGrath EE, Millar AB.

Thorax. 2012 Feb;67(2):97-8. doi: 10.1136/thoraxjnl-2011-201398. Epub 2011 Dec 8. No abstract available.

PMID:
22156778
3.

Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.

Wells AU, Behr J, Costabel U, Cottin V, Poletti V.

Eur Respir J. 2012 Apr;39(4):805-6. doi: 10.1183/09031936.00009112. No abstract available. Erratum in: Eur Respir J. 2012 Jun;39(6):1552.

4.
5.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.

Arthritis Rheum. 2006 Dec;54(12):3962-70.

6.

Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis.

Horita N, Akahane M, Okada Y, Kobayashi Y, Arai T, Amano I, Takezawa T, To M, To Y.

Intern Med. 2011;50(3):189-95. Epub 2011 Feb 1.

7.

Current and future treatment options in idiopathic pulmonary fibrosis.

Hauber HP, Blaukovitsch M.

Inflamm Allergy Drug Targets. 2010 Jul;9(3):158-72. Review.

PMID:
20518722
8.

Where do we stand with IPF treatment?

Albera C, Ferrero C, Rindone E, Zanotto S, Rizza E.

Respir Res. 2013;14 Suppl 1:S7. doi: 10.1186/1465-9921-14-S1-S7. Epub 2013 Apr 16.

9.

[How to face the current status of therapies for idiopathic pulmonary fibrosis].

Zhang DP.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Nov;36(11):844-7. Review. Chinese. No abstract available.

PMID:
24507398
10.

Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.

Brown JH, Douglas AF, Murphy BG, Hill CM, McNamee PT, Nelson WE, Doherty CC.

Nephrol Dial Transplant. 1998 Feb;13(2):443-8.

PMID:
9509460
11.

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial.

Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Lankhorst I, Sardina M, Boissard G; IFIGENIA study group.

Respir Res. 2009 Oct 27;10:101. doi: 10.1186/1465-9921-10-101.

12.

Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis.

Peikert T, Daniels CE, Beebe TJ, Meyer KC, Ryu JH; Interstitial Lung Diseases Network of the American College of Chest Physicians.

Respir Med. 2008 Sep;102(9):1342-8. doi: 10.1016/j.rmed.2008.03.018. Epub 2008 Jul 14.

13.

Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?

Hashemi Sadraei N, Riahi T, Masjedi MR.

Arch Iran Med. 2013 Mar;16(3):177-81. doi: 013163/AIM.0011.

14.

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G.

N Engl J Med. 2014 May 29;370(22):2093-101. doi: 10.1056/NEJMoa1401739. Epub 2014 May 18.

15.

A first step against idiopathic pulmonary fibrosis.

Crestani B.

Eur Respir Rev. 2011 Sep 1;20(121):130-1. doi: 10.1183/09059180.00003711. No abstract available.

16.

Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?

Costabel U.

Eur Respir Rev. 2011 Sep 1;20(121):201-7. doi: 10.1183/09059180.00002011. Review.

17.

Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.

Azuma A.

Expert Rev Respir Med. 2010 Jun;4(3):301-10. doi: 10.1586/ers.10.32. Review.

PMID:
20524912
18.
19.

Recommendations on treatment for IPF.

Behr J, Richeldi L.

Respir Res. 2013;14 Suppl 1:S6. doi: 10.1186/1465-9921-14-S1-S6. Epub 2013 Apr 16.

20.

Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program.

Richeldi L, du Bois RM.

Expert Rev Respir Med. 2011 Aug;5(4):473-81. doi: 10.1586/ers.11.52. Review.

PMID:
21859266

Supplemental Content

Support Center